Therapeutic Innovation

What Therapeutic Innovation does

Therapeutic Innovation, Inc. is a privately held medical device company founded in 2015 and headquartered in Worcester, Massachusetts. The company designs and develops the airbaby™, a Continuous Positive Airway Pressure (CPAP) respiratory support device for premature infants suffering from Respiratory Distress Syndrome (RDS) in developing countries. The device is engineered specifically for resource-limited settings: it operates on both electrical grid power and battery, has a compact transportable form factor, is designed for simple repair and maintenance, uses a reusable model to reduce ongoing cost, and can be operated with minimal training. The company claims airbaby provides 100% CPAP functionality at a fraction of the $8,000–$18,000 cost of Western CPAP systems, with a reported 90% survival rate using CPAP versus 23.5% with nasal oxygen alone.

The company's intellectual property position consists of one international PCT application (WO PCT/US2024/016823) and five US provisional patents covering the device technology, all of which remain pending. No FDA clearance, CE mark, WHO prequalification, or other regulatory approvals are disclosed in available materials. The technology is positioned as a single unified hardware product rather than a platform with multiple SKUs or software components.

Therapeutic Innovation's business model is exclusively hardware sales to government health systems, specifically Ministries of Health and District Medical Stores. The go-to-market is enterprise field sales — partnering directly with national health authorities and integrating into national logistics systems (such as Ghana's GhILMIS) for last-mile delivery to rural hospitals. Stated target markets include Ghana, Kenya, Nigeria, South America, and Southeast Asia, representing a combined addressable opportunity of $2B+ and 5.5M+ devices. The company is currently pre-revenue and is actively soliciting investment capital.

Name

Therapeutic Innovation

Legal name

Therapeutic Innovation, Inc.

Website

https://therapeuticinnovation.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Therapeutic Innovation is a privately held medical device company developing the airbaby™, an affordable, transportable CPAP respiratory device for premature infants with Respiratory Distress Syndrome in developing countries, selling to Ministries of Health and District Medical Stores across Ghana, Kenya, Nigeria, South America, and Southeast Asia.

Ownership category

akta.pro rank

Product category

Neonatal Respiratory Care Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)

akta.pro secondary industries

Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

• Neonatal respiratory devices
• CPAP therapy devices
• Affordable medical hardware
• Premature infant care
• Medical devices emerging markets

Headquarters

HQ city

Worcester

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of airbaby respiratory devices to governments, healthcare systems, and hospitals in developing countries. Revenue derived from direct sales to Ministry of Health partners and district medical stores.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels2 records

Core offering

Therapeutic Innovation sells the airbaby™ device, an affordable, transportable, all-in-one respiratory support device that delivers Continuous Positive Airway Pressure (CPAP) therapy to premature babies suffering from Respiratory Distress Syndrome in developing countries. The device is designed to operate on grid or battery power, be transported to rural facilities, and be easily repaired, maintained, and operated with minimal training, providing full CPAP functionality at a fraction of the cost of Western devices.

Product overview

Therapeutic Innovation offers a single unified product: the airbaby™ device. This is an all-in-one respiratory support device specifically engineered for premature infants in developing countries. The airbaby™ combines CPAP functionality, portability, battery operation, and reusability into one compact unit, addressing the limitations of traditional Western medical equipment that requires stable power infrastructure and complex maintenance.

Differentiator

Problem solved

Functional benefit

Brands

• airbaby™: The first affordable, transportable, all-in-one device to combat respiratory distress in premature babies for developing countries. Features include grid/battery operation, life-saving features, simple repair and maintenance, reusable model, and trainable with support. Patents pending.

Products and services

• airbaby™ An affordable, transportable, all-in-one medical device that delivers Continuous Positive Airway Pressure (CPAP) therapy to premature babies with Respiratory Distress Syndrome in developing countries. Operates on grid or battery power, is reusable, designed for simple repair and maintenance, and is trainable with minimal instruction, providing 100% CPAP functionality at a fraction of the cost of Western devices ($8,000-$18,000).

Quantifiable outcome

• 90% survival rate with CPAP therapy using airbaby vs 23.5% with nasal O2 alone
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Ghana Health Service / Ministry of HealthcoreChannel Partner/ Reseller/ DistributorIntegration of airbaby into Ghana's national logistics system (GhILMIS) for seamless medical supply management. Partnership with Ministry of Health's rural District Medical Stores (DMS) to ensure device availability and last-mile delivery to remote hospitals.
• District Medical Stores (DMS)coreChannel Partner/ Reseller/ DistributorGovernment-operated medical supply distribution network in Ghana enabling last-mile delivery of airbaby devices to rural healthcare facilities.
• Harvard T.H. Chan School of Public HealthminorStrategic or Co-development PartnerExpert advisor Rebecca Schechter from Harvard School of Public Health provides advisory support for global health strategy and research.
• Johnson & JohnsonminorStrategic or Co-development PartnerBoard member Ibrahim Badejo serves as Senior Director, New Ventures at J&J, providing strategic guidance and healthcare industry expertise.
• Chorus (Health Innovation Company)minorStrategic or Co-development PartnerBoard member Scott Rader, PhD serves as Chief Innovation Officer at Chorus, contributing healthcare innovation expertise.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pumani (Hadleigh Health Technologies / 3rd Stone Design): Pumani is widely regarded as the pioneering low-cost bubble CPAP for neonatal respiratory distress in African settings (originating in Malawi). It is the most direct functional competitor to airbaby, targeting the same neonatal RDS patient population in low-resource hospitals.
• Vayu Global Health: Vayu Global Health develops low-cost, durable bubble CPAP and other respiratory devices specifically for low- and middle-income countries. It overlaps with Therapeutic Innovation in customer base (emerging-market hospitals/governments) and core technology (affordable neonatal CPAP).

Broad incumbents

• ResMed: ResMed is the global CPAP market leader for sleep apnea and respiratory care, primarily serving developed markets. Therapeutic Innovation sits at the opposite price/geo point of the same CPAP therapy category.
• Drägerwerk (Dräger): Dräger manufactures neonatal respiratory support equipment (ventilators, CPAP, warmers) used in hospitals worldwide. It is a broad incumbent in the same neonatal respiratory device category as airbaby.
• Fisher & Paykel Healthcare: Fisher & Paykel is a major incumbent in respiratory care devices, including neonatal CPAP circuits and humidification systems used in NICUs globally. Its technology and clinical positioning overlap with Therapeutic Innovation's CPAP therapy focus.
• Philips Respironics: Philips Respironics is a leading provider of CPAP/APAP/BiPAP devices and hospital respiratory solutions. It competes in the same CPAP therapy category but at higher price points and developed-market focus.

Emerging players

• Phoenix Medical Systems: Phoenix manufactures affordable neonatal care equipment (CPAP, phototherapy, infant warmers) primarily for India and other emerging markets. It is comparable as a value-engineered neonatal respiratory device maker serving resource-limited hospitals.
• D-Rev (now Equalize Health): Equalize Health (formerly D-Rev) designs affordable medical devices for underserved populations globally. It is comparable as a mission-driven medical device company targeting low-resource hospitals in emerging economies.
• Gradian Health Systems: Gradian supplies and services anesthesia and critical care equipment for hospitals in low- and middle-income countries, with a business model built on training and maintenance. It overlaps in distributing and sustaining complex medical devices where infrastructure is weak.
• Laerdal Global Health: Laerdal Global Health focuses on affordable, training-focused medical devices for low-resource settings, including neonatal resuscitation and respiratory care solutions. It addresses the same low-cost, easy-to-train emerging-market hospital segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/therainnovation
• LinkedInlinkedin.com/company/therapeuticinnovation

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds7 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Therapeutic Innovation